Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000025912
JPRN-UMIN000025912
Completed
未知

Feasibility Study of Continuous Intervention with Designated Treatment Application for NASH (Non-Alcoholic Steatohepatitis) Patients - Continuous Intervention of Application for NASH patients

Department of Gastroenterology, The University of Tokyo0 sites9 target enrollmentJanuary 31, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Gastroenterology, The University of Tokyo
Enrollment
9
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Since one patient was lost to follow-up, the comparison between pre- and post-intervention values was performed for 8 patients. A post-intervention weight reduction was observed in 7 patients, and this weight reduction was statistically significant (p=0.02).Normalization of the ALT level (<30 U/L) was observed in two patients.

Registry
who.int
Start Date
January 31, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Gastroenterology, The University of Tokyo

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •exclusion criteria 1\. a patient does not agree 2\. a patient who the attending physician think is does not seem able to use a smartphone. 3\. pregnant patients. 4\. patients with comorbid hepatitis (e.g., viral hepatitis, autoimmune hepatitis)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Observational Study of Complications Related to Use of Peripherally Inserted Central CathetersAdult Patients With Peripherally Inserted Central Catheters
NCT01578993Teleflex101
Completed
Not Applicable
An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized TrialSarcoma
NCT00384735Terry Fox Foundation500
Completed
Phase 4
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney DiseaseAnemiaRenal Insufficiency, ChronicRenal Anemia
NCT05951192USRC Kidney Research161
Active, not recruiting
Phase 1
A phase IV interventional study to assess the disease-modifying effect of long-term treatment with tildrakizumab in adult patients with moderate-to-severe plaque psoriasisModerate to severe plaque psoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2019-003218-15-PLAlmirall S.A.47
Completed
Phase 4
Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and UzbekistanMedical Abortion, Fetus
NCT01410266Gynuity Health Projects2,400